{"DataElement":{"publicId":"3849480","version":"2","preferredName":"Other Leukemia Status Atypical Chronic Myeloid Leukemia Type","preferredDefinition":"A description of the disease status atypical chronic myeloid leukemia for other leukemia.","longName":"3844232v1.0:3946572v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3844232","version":"1","preferredName":"Other Leukemia Status","preferredDefinition":"Different than the one(s) previously specified or mentioned._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._A condition or state at a particular time.","longName":"2685376v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2685376","version":"1","preferredName":"Other Leukemia","preferredDefinition":"Not otherwise specified.:A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","longName":"C17649:C3161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAD6C97-F7CC-1A52-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E37048E2-01BB-C58E-E040-BB89AD4363B7","latestVersionIndicator":"Yes","beginDate":"2013-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3946572","version":"1.1","preferredName":"Atypical Chronic Myeloid Leukemia Status Type","preferredDefinition":"A myelodysplastic/myeloproliferative neoplasm characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia.  The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL fusion gene.  The prognosis is usually poor.  (WHO, 2001)_A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"3946572v1.1","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1st complete remission (no previous bone marrow or extramedullary relapse)","valueDescription":"Complete Response, Preliminary","ValueMeaning":{"publicId":"2770751","version":"1","preferredName":"Complete Response, Preliminary","longName":"2770751","preferredDefinition":"Preceding all others in time or space or degree.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53E0F58A-823C-509B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-636D-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":">= 3rd relapse","valueDescription":"Greater Than or Equal To Integer::3 Recurrent Disease","ValueMeaning":{"publicId":"3053622","version":"1","preferredName":"Greater Than or Equal To Integer::3 Recurrent Disease","longName":"3053622","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::3: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83970E6A-72A1-0B56-E040-BB89AD435258","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-63DB-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":"1st relapse","valueDescription":"First Recurrent Disease","ValueMeaning":{"publicId":"2769848","version":"1","preferredName":"First Recurrent Disease","longName":"2769848","preferredDefinition":"Preceding all others in time or space or degree.: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A199B4-7362-3A66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-6381-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":"2nd complete remission","valueDescription":"Second Complete Remission","ValueMeaning":{"publicId":"2769849","version":"1","preferredName":"Second Complete Remission","longName":"2769849","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A199B4-738A-3A66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-638B-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":"2nd relapse","valueDescription":"Second Recurrent Disease","ValueMeaning":{"publicId":"2769850","version":"1","preferredName":"Second Recurrent Disease","longName":"2769850","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A199B4-73AF-3A66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-6395-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":"No treatment","valueDescription":"No Treatment","ValueMeaning":{"publicId":"3053621","version":"1","preferredName":"No Treatment","longName":"3053621","preferredDefinition":"The non-affirmative response to a question.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83970E6A-727A-0B56-E040-BB89AD435258","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-639F-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":"Primary induction failure (PIF)","valueDescription":"Primary Induction Failure","ValueMeaning":{"publicId":"3072088","version":"1","preferredName":"Primary Induction Failure","longName":"3072088","preferredDefinition":"A disease status whereby the patient does not achieve a complete remission. It may not be limited to the first/initial course of therapy; it may represent all courses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Induction Failure","conceptCode":"C70622","definition":"A disease status whereby the patient does not achieve a complete remission. It may not be limited to the first/initial course of therapy; it may represent all courses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B2D65C-DED6-69FB-E040-BB89AD432401","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-63A9-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"},{"value":">= 3rd complete remission","valueDescription":"Greater Than or Equal To Integer::3 Complete Remission","ValueMeaning":{"publicId":"3072089","version":"1","preferredName":"Greater Than or Equal To Integer::3 Complete Remission","longName":"3072089","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::3: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B2D65C-DEFD-69FB-E040-BB89AD432401","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEB81F74-63D1-96D4-E040-BB89AD431F7B","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"ONEDATA","dateModified":"2014-07-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3946571","version":"1","preferredName":"Atypical Chronic Myeloid Leukemia Status Type","preferredDefinition":"A myelodysplastic/myeloproliferative disease characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia.  The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL fusion gene.  The prognosis is usually poor.  (WHO, 2001) -- 2003:A condition or state at a particular time.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3519:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Chronic Myeloid Leukemia","conceptCode":"C3519","definition":"A myelodysplastic/myeloproliferative neoplasm characterized by the presence of leukocytosis with increased numbers of neutrophils, promyelocytes, myelocytes, and metamyelocytes; blasts less than 20% in bone marrow and peripheral blood; dysgranulopoiesis; minimal or absent monocytosis; absence of eosinophilia; and presence of bone marrow hypercellularity with granulocytic proliferation and granulocytic dysplasia. Dysplasia in the erythroid and megakaryocytic lineages may be present or absent. No evidence of BCR/ABL fusion is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA872AD2-6D5C-CB3C-E040-BB89AD4313A5","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-06","modifiedBy":"ONEDATA","dateModified":"2013-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB81F74-634D-96D4-E040-BB89AD431F7B","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PreTed_prime_dis_hct_oth_lk_atyp_cml_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_OL_oth_lk_atyp_cml_stat","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the other leukemia st","type":"Preferred Question Text","description":"What is the other leukemia status atypical chronic myeloid leukemia type?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Alternate Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Application Standard Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D262-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-07-21","modifiedBy":"KUMMEROA","dateModified":"2019-07-01","changeDescription":". Added human readable def. AK 11/18/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}